MEDICAL RESEARCH AND DEVELOPMENT CONTRACT DHA SBIR PH II, PROPOSAL NO. H2S-0048, TITLED: "GW-TT2, A NEW DRU…
Award details are derived from public USAspending.gov records. Not a bid recommendation.
Award details
- Award ID
- HT942523C0071
- Contractor
- GATEWAY BIOTECHNOLOGY, INC
- Awarding agency
- Department of Defense
- Sub-agency / office
- Defense Health Agency
- Award amount
- $1,299,999
- Period of performance
- Sep 18, 2023 – Jan 17, 2027
- NAICS
- 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- PSC
- PSC AN12
- Place of performance
- ROOTSTOWN, OH, 442729698, USA
- Competition
- FULL AND OPEN COMPETITION AFTER EXCLUSION OF SOURCES · Set-aside: SMALL BUSINESS SET ASIDE - TOTAL · 1 offers
- Pricing
- FIRM FIXED PRICE
- Financial breakdown
- Current value $1,299,999 · Obligated $1,299,999 · Potential value $1,299,999 · Latest action obligation $0
Public award description
MEDICAL RESEARCH AND DEVELOPMENT CONTRACT DHA SBIR PH II, PROPOSAL NO. H2S-0048, TITLED: "GW-TT2, A NEW DRUG PRODUCT FOR TINNITUS"
Find out who's winning similar federal contracts
Discover comparable awards, related contractors, and agency purchasing history.